Joseph P. Slattery sold $3.03M worth of shares in TransEnterix, Inc. in June 2018
Jul 08, 2018
Executive Vice President & Chief Financial Officer at TransEnterix, Inc.
In The News
TransEnterix Schedules Second Quarter Financial and Operating Results Conference Call for August 7, 2019
Jul 25, 2019 - Business Wire
Jun 25, 2019 - RelSci
Jun 06, 2019 - Business Wire
TransEnterix, Inc. is a medical device company. It focuses on commercialization of Senhance System, that digitizes laparoscopic minimally invasive surgery. It offers the Senhance Surgical Robotic System, which offers robotic surgery for laparoscopic abdominal and pelvic surgery, as well as limited thoracic operations excluding cardiac and vascular surgery, and the SurgiBot System which refers to the a single-port, robotically enhanced laparoscopic surgical platform. The company was founded by William N. Starling in 2006 and is headquartered in Morrisville, NC.
In The News
TransEnterix Announces Broad Reimbursement Approval in Japan for Senhance Digital Laparoscopy System
Aug 01, 2019 - Business Wire
Bariatric Surgery Devices Market Is Projected To Reach USD 2200 Million With Expanding at a CAGR of 5.5% By 2023 | MRFR
Jul 31, 2019 - GlobeNewswire